(Q37663468)

21 August 2017

Mitoxantrone in worsening secondary progressive multiple sclerosis: A prospective, open-label study (English)

1 reference

secondary progressive multiple sclerosis

21 August 2017

0 references

multiple sclerosis

0 references

author name string

Bhupendra O Khatri

1

1 reference

21 August 2017

Mary Wroblewski

2

1 reference

21 August 2017

John Kramer

3

1 reference

21 August 2017

Mary Dukic

4

1 reference

21 August 2017

Arleen Poplar

5

1 reference

21 August 2017

A J Anderson

6

1 reference

21 August 2017

1 January 2006

1 reference

Current Therapeutic Research

21 August 2017

1 reference

21 August 2017

67

1 reference

21 August 2017

1

1 reference

21 August 2017

55-65

1 reference

The use of mitoxantrone (Novantrone) for the treatment of multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

21 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3965966

A study of therapy-related acute leukaemia after mitoxantrone therapy for multiple sclerosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3965966

Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3965966

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3965966

Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3965966

An open-trial evaluation of mitoxantrone in the treatment of progressive MS.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3965966

A case of acute promyelocytic leukaemia following mitoxantrone treatment of multiple sclerosis.

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3965966

Acute Myelogenous Leukemia Following Xmitoxantrone Treatment for Multiple Sclerosis

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3965966

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3965966

Severe heart failure in a young multiple sclerosis patient

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3965966

Rapid onset mitoxantrone-induced cardiotoxicity in secondary progressive multiple sclerosis

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3965966

Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3965966

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3965966

A double-blind clinical trial of mitoxantrone versus methylprednisolone in relapsing, secondary progressive multiple sclerosis

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3965966

The natural history of multiple sclerosis

1 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24678083

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Acute promyelocytic leukemia following mitoxantrone as single agent for the treatment of multiple sclerosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24678083

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24678083

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.CURTHERES.2006.02.004

1 reference

21 August 2017

1 reference

21 August 2017

PubMed publication ID

24678083

1 reference